Patents
Patents for C07K 19 - Hybrid peptides (29,428)
07/2007
07/17/2007US7244613 Expression vector comprising nucleotide sequences coding tubercular complex for use in developing vaccines for treatment and prevention of respiratory system disorders; bactericides
07/17/2007US7244589 Chimeric immunogens
07/12/2007WO2007077008A1 Chimaeric fusion protein with superior chaperone and folding activities
07/12/2007WO2007076927A1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130
07/12/2007US20070161054 Methods and compositions for targeting secretory lysosomes
07/12/2007US20070161045 Fusion proteins based upon somatostatin receptors
07/12/2007US20070160631 Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes
07/12/2007US20070160630 Hepatitis-c virus 4, 5 and 6
07/12/2007US20070160594 Method of Diagnosing and Treating Cartilaginous Disorders
07/12/2007US20070160575 Anth1 chimeric antagonist
07/12/2007US20070160534 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands
07/12/2007CA2635615A1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130
07/11/2007EP1806402A2 CTLA4/CD28 ligands and uses therefor
07/11/2007EP1806143A2 Baff receptor (BCMA), an immunoregulatory agent
07/11/2007EP1804831A2 Listeria-based and llo-based vaccines
07/11/2007EP1218504B1 Gl50 molecules and uses therefor
07/11/2007EP1146889B1 IDENTIFICATION OF SPECIFIC DIFFERENTIALLY EXPRESSED MYCOBACTERIAL ANTIGENS AND MEDICAL USE OF THE MYCOBACTERIAL PROTEINS Rv0068 AND Rv3407
07/11/2007EP1071767B1 Gene coding for heliomicine and use thereof
07/11/2007EP0975771B1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins
07/11/2007EP0808367B1 Mucosal vascular addressins and uses thereof
07/11/2007CN1997386A Methods of treating type I diabetes by blocking VEGF-mediated activity
07/11/2007CN1995065A Fusion protein for suppressing PTTG expression and its coding gene and uses
07/11/2007CN1995064A Long-lasting recombinant human red blood cell growth factor fusion protein and method
07/11/2007CN1325649C Gene recombinant human cytomegalovirus fusion protein pp150/MDBP, preparation process and application thereof
07/11/2007CN1325644C Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
07/11/2007CN1325513C Oil bodies and associated proteins as affinity matrices
07/11/2007CN1325512C Fusion protein of HIV regulatory/accessory proteins
07/10/2007US7241880 T1R taste receptors and genes encoding same
07/10/2007US7241879 polynucleotide comprising a coding sequence for a multiple epitope fusion antigen which reacts specifically with anti-Hepatitis C Virus (HCV) antibodies; expression vectors and host cells; use in sensitive, accurate test; e.g. to detect HCV in blood for transfusion
07/10/2007US7241877 Humanised antibodies
07/10/2007US7241862 Polypeptides that induce cell proliferation or induce fetal hemoglobin
07/10/2007US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
07/10/2007US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
07/10/2007US7241593 Comprises fusion protein comprising platelet derived growth factor for treating connective tissue, tumor and bone disorders
07/10/2007CA2060455C Reverse antimicrobial peptides, antimicrobial oligopeptides and other antimicrobial compositions, and methods of their production and use, particularly to provide protection against plant pathogens
07/10/2007CA2007248C Meningococcal class 1 outer-membrane protein vaccine
07/05/2007WO2002038805A8 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
07/05/2007US20070157328 Suppression of xenotransplant rejection
07/05/2007US20070155668 Peptides modulating the activity of the engrailed transcription factor
07/05/2007US20070154991 Transgenic bacillus for use as bioreactor in production of capsular polysaccharide A
07/05/2007US20070154486 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin
07/05/2007CA2836123A1 Compositions and methods for producing a composition
07/05/2007CA2634016A1 Compositions and methods for treating obesity and related metabolic disorders
07/04/2007EP1803816A2 Mammalian cell surface antigens; related reagents
07/04/2007EP1803810A1 Integrin antagonists
07/04/2007EP1803730A1 Albumin fusion proteins
07/04/2007EP1802645A2 Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin b-subunit and uses thereof
07/04/2007EP1551862B1 Protein lattice
07/04/2007EP1523558B1 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies
07/04/2007EP1121382B9 Interferon-beta fusion proteins and uses
07/04/2007EP0868435B1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein
07/04/2007CN1993378A Rage fusion proteins and methods of use
07/03/2007US7238859 Ecdysone receptors and methods for their use
07/03/2007US7238786 For use in diagnosis and therapy
07/03/2007US7238667 Albumin fusion proteins
07/03/2007US7238507 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
07/03/2007US7238499 Trimeric macrophage scavenger receptor fusion proteins and encoding nucleic acids
07/03/2007US7238360 Getting the same result as gene therapy, without the introduction of exogenous DNA, by binding T cell with immunomodulator biotin, then contacting with avidin or streptavidin; apoptosis induction or resistance
07/03/2007CA2295199C Method for treating vascular proliferative diseases with p27 and fusions thereof
06/2007
06/28/2007WO2007073147A1 Apoptosis-inducing protein complexes and therapeutic use thereof
06/28/2007WO2007071962A1 Polypeptide targeting to mitochondria
06/28/2007WO2007071068A1 Process for the production of preformed conjugates of albumin and a therapeutic agent
06/28/2007WO2007071062A1 Methods and compositions for the detection and isolation of ligands
06/28/2007WO2007071061A1 Methods for generating and screening fusion protein libraries and uses thereof
06/28/2007WO2006090385A3 Protease inhibitors and method of screening thereof
06/28/2007US20070150973 Genetically engineering cell to regulate expression of gene target via nucleic acid coding fusion protein having transcription regulatory domain and composite DNA binding domain; gene therapy
06/28/2007US20070149770 Poly zinc finger proteins with improved linkers
06/28/2007US20070149769 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
06/28/2007US20070149766 Method for producing a recombinant protein of interest and protein thus produced
06/28/2007US20070149455 Modified and stabilized gdf propeptides and uses thereof
06/28/2007US20070148774 Methods for producing members of specific binding pairs
06/28/2007US20070148731 Expression control sequence cassette; a nucleotide sequence of a lac operator sequence to which a lacI repressor protein specifically binds a mutated lac; modification of the nucleotide sequence within a T5 promoter/lac operator expression control sequence provides a stable promoter/operator
06/28/2007US20070148143 Human cytokine receptor
06/28/2007CA2634624A1 Polypeptide targeting to mitochondria
06/28/2007CA2634495A1 Process for the production of preformed conjugates of albumin and a therapeutic agent
06/28/2007CA2634292A1 Apoptosis-inducing protein complexes and therapeutic use thereof
06/28/2007CA2633790A1 Methods and compositions for the detection and isolation of ligands
06/28/2007CA2633138A1 Methods for generating and screening fusion protein libraries and uses thereof
06/27/2007EP1801216A2 Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation
06/27/2007EP1355936B1 Polymer conjugates of neublastin and methods of using same
06/27/2007CN1986814A Fusion expressed product of vascular inhibine and endostatin in colibacillus and its preparing method
06/27/2007CN1323164C Protein complex, process for producing the same and use thereof
06/26/2007US7235374 Systems for sensitive detection of G-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation
06/26/2007CA2265464C Therapy for .alpha.-galactosidase a deficiency
06/26/2007CA2154445C Lysosomal targeting of immunogens
06/21/2007WO2007069604A1 Method for production of modified protein
06/21/2007WO2007068313A2 Targeting and tracing of antigens in living cells
06/21/2007WO2007068047A1 Multimeric fc receptor polypeptides
06/21/2007WO2006101782A3 A cysteine-containing peptide tag for site-specific conjugation of proteins
06/21/2007US20070142295 Thrombopoietic compounds
06/21/2007US20070141087 Compounds and methods for diagnosis of tuberculosis
06/21/2007US20070141085 Recombinant protective protein from Streptococcus pneumoniae
06/21/2007US20070141081 Proteins for use as vaccine to prevent dengue virus infection; immunotherapy; high serotype-specificity to be used in humans
06/21/2007CA2628388A1 Targeting and tracing of antigens in living cells
06/20/2007EP1798288A2 Human Toll-like receptor proteins, related reagents and methods
06/20/2007EP1798287A2 Mammalian cell membrane proteins and related reagents
06/20/2007EP1798286A2 Mammalian cell membrane proteins and related reagents
06/20/2007EP1797127A2 Modified fc molecules
06/20/2007EP1623036A4 Identification of novel nogo-receptors and methods related thereto
06/20/2007EP1532239A4 Methods and compositions for targeting secretory lysosomes